China RSABE [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-01-04 15:49 (206 d 17:52 ago) – Posting: # 22170
Views: 774

Hi 0521,

» It looks great, maybe you can open up editing permissions to allow others to create comparison tables of words and descriptions in other languages.

Sorry, no way – we are already blocking more than 20 registration attempts by bots and script-kiddies per day. Hence, no write-permission for any file. The language of the site is (bad) English. :cool:

» "RSABE of highly variable drugs" is that.
»
» Beijing time: October 29, 2018, public.
»
» Chinese: 高变异药物生物等效性研究技术指导原则
» English: Guidance for Industry: the study of drug bioequivalence with highly variable drugs
»
» webpage:
» http://www.cde.org.cn/zdyz.do?method=largePage&id=3fa6c1797e66be98
»
» PDF:
» http://www.cde.org.cn/attachmentout.do?mothed=list&id=caf29fdd9abce51e

THX, again.

The site can’t be reached right now (I tried seven different browsers). Ping and traceroute timed out. Will try later.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,592 posts in 4,514 threads, 1,532 registered users;
online 9 (0 registered, 9 guests [including 5 identified bots]).
Forum time: Friday 10:41 CEST (Europe/Vienna)

It is a capital mistake to theorise before one has data.    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5